Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Genes® and FDA to Co-Sponsor FREE Rare Disease Public Workshop October 30

Global Genes
Posted on: 11 Oct 17
Global Genes® and FDA to Co-Sponsor FREE Rare Disease Public Workshop October 30 Strategies, Tools and Best Practices for Effective Patient Involvement in Rare Disease Drug Development

PR Newswire

ALISO VIEJO, Calif., Oct. 11, 2017

ALISO VIEJO, Calif., Oct. 11, 2017 /PRNewswire-USNewswire/ -- Global Genes®, one of the world's leading rare disease patient advocacy organizations, is proud to announce a partnership with the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to co-sponsor a FREE one-day public workshop on Monday, October 30, from 8 a.m. - 4 p.m. The workshop will be hosted at the FDA's White Oak Campus in Silver Spring, Maryland.

The FREE workshop will offer a unique opportunity for the public to learn top strategies, tools, and best practices for effective communication and patient involvement to better promote rare disease drug development with the FDA's CDER. Patients and attendees will have the opportunity to learn the role of the FDA and CDER through examples with case studies, and will also meet the patient engagement team from the rare disease sector at the federal agency level. The workshop will provide insight into how the FDA grants designations that reflect current science and drug development, and the public health goals intended by Congress.

Monday, October 30, 2017
8:00 am – 4:00 pm

FDA White Oak Campus
10903 New Hampshire Avenue Bldg. 31, Room 1503 (Great Room)
Silver Spring, Maryland 20993

Registration is available on a first-come, first-served basis. Seating is limited, and early registration is suggested. To view the agenda and to register, please visit

About Global Genes®
Guided by its mission to eliminate the challenges of rare disease, Global Genes® is one of the world's leading rare disease patient advocacy organization with worldwide reach that serves and promotes the needs of patients and families touched by rare and genetic diseases. Since 2009, under the unifying symbol of HOPE and the Blue Denim Genes Ribbons®, Global Genes® has been building awareness, developing patient-focused education and advocacy tools, and funding patient care programs and early investigative research. For more information visit and join the RARE conversation! Follow @GlobalGenes on social media.

About Food and Drug Administration (FDA)
The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation. FDA has also responsibility to protect Americans from tobacco-related death and disease by regulating the manufacture, distribution, and marketing of tobacco products and by educating the public, especially young people, about tobacco products and the dangers their use poses to themselves and others.

About Center for Drug Evaluation and Research (CDER)
CDER's mission is to protect and promote public health by helping to ensure that human drugs are safe and effective for their intended use, that they meet established quality standards, and that they are available to patients.


View original content with multimedia:

SOURCE Global Genes

PR Newswire

Last updated on: 11/10/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.